Drug Approval | August 13, 2022
Lupin receives USFDA approval for Meclizine Hydrochloride Tablets USP
The product will be manufactured at Lupin’s facility in Goa, India.
The product will be manufactured at Lupin’s facility in Goa, India.
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
Lupin is the 6th largest company in the Indian Pharmaceutical Market
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Subscribe To Our Newsletter & Stay Updated
